Cameco: BMO Lifts Price Target To $42 Following Positive Uranium Price Move

On March 30th, BMO Capital Markets raised their rating and 12-month price target on Cameco (TSX: CCO). BMO raised their rating from market perform to outperform, and increased their price target from $33 to $42. The analyst indicated that the lift was due to the limited number of listed producers, the rise in countries wanting low carbon nuclear generation, and the security of supply becoming a forefront issue.

“Cameco’s advantageous geographical production base and its position as the largest and most liquid uranium stock means there should be further upside to its stock price.”

Cameco currently has 13 analysts covering the stock with an average 12-month price target of C$38.53, which represents a 6% upside to the current stock price. Out of the 13 analysts, 4 have strong buy ratings, 7 have buy ratings while the last 2 analysts have hold rating on the stock. The street high sits at C$45 from TD Securities, which represents a 24% upside to the current price.

Emerita Resources Corp. — sponsored Sponsored · Emerita Resources Corp.

BMO has gone ahead and increased its near-term uranium prices by 13% for 2022 and 3% for 2023, to an average of US$51/lb and US$46/lb respectively. For the company, this means that they now expect “a modest” increase in Cameco’s near-term cash flow as well a their EBITDA.

The analyst at BMO says that the change in global sentiment will work out for Cameco, as the support for nuclear power continues to grow in countries all around the world, which means governments are looking at either increasing the lifespan of working nuclear facilities or reopening previously closed nuclear power plants. Either option will increase the near-term demand, which is “underpinning increasingly positive sentiment in the sector.”

Lastly, they add that the tragic events in Ukraine “has brought security of supply into sharper focus,” which includes many commodities such as Uranium, as it offers a low carbon alternative to fossil fuels. BMO believes that due to Cameco’s “advantageous location” as it’s close to the world’s largest nuclear fleet in the U.S, “we believe Cameco is increasingly likely to benefit from positive contracting discussions with utilities following on from the promising start reported this year.”

Below you can see BMO’s updated 2022 and 2023 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Molybdenum Is Up 68% This Year. Nobody’s Talking About It. | EraNova PEA

Why Is This $1.5 Billion Gold Story Worth Just $37 Million? | Fredonia Mining PEA

This Copper Stock Exploded Before Anyone Knew the Grade | Decade Resource

Recommended

Mercado Minerals Signs LOI for La Franca, Adding 750 Metres of Undrilled Vein at Zamora

Goliath Hits Visible Gold In Bonanza Zone Step-Outs, Drills 9.12 g/t Gold Equivalent Over 11.27 Metres

Related News

BMO Cuts Roger Communications’ Price Target After Boardroom Drama Flares Up

On October 8th, The Globe and Mail reported on the recent and abrupt departure of...

Sunday, October 17, 2021, 01:07:00 PM

Cannabis Earnings: Cantor Fitzgerald Adjusts Ratings Ahead Of Earnings

Last week, Pablo Zuanic from Cantor Fitzgerald released his second-quarter estimates and updated his 12-month...

Wednesday, August 11, 2021, 09:56:00 AM

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Hecla Mining: Canaccord Reduces Price Target To $5.75 Following Earnings

Thursday, Hecla Mining (NYSE: HL) reported their fourth quarter and full year 2020 financial results....

Saturday, February 20, 2021, 02:34:00 PM

Columbia Care: Analysts Expect $17.2 Million In Q2 EBITDA

Columbia Care Inc. (CSE: CCHW) announced that they will be reporting their second quarter financials...

Tuesday, August 10, 2021, 11:51:00 AM